Andrographolide Induces Mitochondrial Dysfunction and Alters Stemness-related Gene Expression in MCF7 Breast Cancer

Natthima Suwan1, Sasipat Teerawongsuwan2, Sirinya Jenjittikul1

  • 1Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.

Anticancer Research
|December 30, 2025
PubMed
Abstract

Insights

Andrographolide shows anti-cancer effects by inducing mitochondrial dysfunction and apoptosis. Paradoxically, it increases OCT4 (octamer-binding transcription factor 4) expression, potentially indicating an adaptive survival mechanism in cancer cells.

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Cellular Biology

Background:

  • Andrographolide from *Andrographis paniculata* shows anti-cancer potential.
  • Its impact on cancer stemness and pluripotency, crucial for treatment resistance, is not well understood.

Purpose of the Study:

  • To investigate the effects of andrographolide on cancer cell pluripotency and stemness.
  • To elucidate the mechanisms underlying andrographolide's anti-cancer activity.

Main Methods:

  • MCF7 cells were treated with varying concentrations of andrographolide.
  • Assays included MTT for viability, TMRE for mitochondrial potential, RT-qPCR for gene expression (TOMM20, OCT4, BAX, etc.), and mammosphere/colony formation assays.

Main Results:

  • Andrographolide reduced cell viability and mitochondrial membrane potential, indicating dysfunction.
  • It upregulated BAX and OCT4 (octamer-binding transcription factor 4) expression, suggesting apoptosis induction and a shift towards pluripotency.
  • Reduced mammosphere and colony formation indicated decreased cancer stemness.

Conclusions:

  • Andrographolide exhibits anti-cancer properties via mitochondrial dysfunction and apoptosis.
  • The observed increase in OCT4 expression suggests a potential adaptive survival response, linked to cancer stem-like characteristics.